Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men

This randomized, open‐label, multiple‐dose three‐way cross‐over study compared the pharmacokinetics of a new testosterone gel formulation in two strengths, testosterone gel 1% and testosterone gel 2% (FE 999303), with Testogel® in 11 testosterone‐suppressed healthy men. Subjects received one of six...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology in drug development 2014-09, Vol.3 (5), p.358-364
Hauptverfasser:	Olsson, Håkan, Sandström, Rikard, Neijber, Anders, Carrara, Dario, Grundemar, Lars
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Cutaneous Adolescent Adult Androgens Area Under Curve bioavailability Biological Availability Cross-Over Studies dihydrotestosterone Drug Administration Schedule Drug Compounding gel Gels Germany Half-Life Healthy Volunteers Hormone Replacement Therapy Humans Male Metabolic Clearance Rate Middle Aged pharmacokinetics Sexual behavior Skin Absorption Testosterone Testosterone - administration & dosage Testosterone - blood Testosterone - chemistry Testosterone - pharmacokinetics Therapeutic Equivalency Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!